Stay updated on Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial
Sign up to get notified when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page.

Latest updates to the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the study record history.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added; the government-funding notice and the v3.4.1 entry were removed.SummaryDifference0.7%

- Check41 days agoChange DetectedA site-wide notice about government funding lapse and updated status was added, and the history shows Release Revision: v3.4.1 with v3.4.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check48 days agoChange DetectedNew version introduces UI updates: a Show glossary option and color-coded highlights to distinguish additions and deletions, along with a Revision: v3.4.0 header. The No FEAR Act Data label is updated.SummaryDifference0.9%

- Check62 days agoChange DetectedThe history shows a new revision entry (v3.3.4) and removal of v3.3.3, which are metadata changes to the record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the history. These appear to be site maintenance/versioning updates rather than changes to trial data or user-facing functionality.SummaryDifference0.2%

Stay in the know with updates to Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page.